Basics IDEAYA Biosciences, Inc. IPO Date: May 20, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.97B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.96% Avg Daily Range (30 D): $0.42 | 1.94% Avg Daily Range (90 D): $0.53 | 2.89% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): 1M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 67 Institutional Trades Total Inst.Trades: 2,283 Avg Inst. Trade: $2.4M Avg Inst. Trade (30 D): $2.42M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.02M Avg Closing Trade (30 D): $3.67M Avg Closing Trade (90 D): $3.59M Avg Closing Volume: 116.51K     News Jul 10, 2024 @ 12:01 PM Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.... Source: Avi Kapoor Jul 9, 2024 @ 12:31 PM Company News for July 9, 2024 - July 9, 2024 - Zac... Source: N/A Jul 8, 2024 @ 8:17 PM BTIG lifts Ideaya Biosciences target to $62 on stu... Source: Lina Guerrero Jul 8, 2024 @ 9:40 AM Why Paramount Global Shares Are Trading Higher By ... Source: Avi Kapoor May 8, 2024 @ 5:01 PM Unveiling 5 Analyst Insights On IDEAYA Biosciences... Source: Benzinga Insights Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.65 $-.82 $-1.55 Diluted EPS $-3.65 $-.82 $-1.55 Revenue $ 7M $ M $ 7M Gross Profit $ $ $ Net Income / Loss $ -307.08M $ -72.18M $ -130.31M Operating Income / Loss $ -360.35M $ -84.39M $ -144.14M Cost of Revenue $ $ $ Net Cash Flow $ 21.7M $ 45.62M $ -316.01M PE Ratio